Struggling with Increased Sensitivity: PSMA PET/CT - Michael Hofman

Presentation from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.   (Length of video ~ 23 minutes)

Michael Hofman discusses PSMA as the new “gold standard” and how it is significantly superior to existing imaging modalities through case studies from the Peter MacCallum Cancer Centre and a review of abstracts.

Related content:
Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer.

68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.

AUA 2017: 11C-Choline versus 68ga-PSMA PET/CT scan for the detection of nodal recurrence from prostate cancer: results from a large, multi-institutional salvage lymph node dissection series

Michael Hofman
Associate Professor
Molecular Imaging,Centre for Cancer Imaging
Peter MacCallum Cancer Centre/The University of Melbourne